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Background: Chronic cyanosis in adults with congenital heart disease (CHD) may cause structural brain changes
that could contribute to impaired neurological functioning. The extent of these changes has not been adequately
characterized.
Hypothesis:Wehypothesized that adultswith cyanotic CHDwouldhavewidespread changes including abnormal
brain volumetric measures, decreased cortical thickness and an increased burden of small and large vessel ische-
mic changes.
Methods: Ten adults with chronic cyanosis from CHD (40 ± 4 years) and mean oxygen saturations of 82 ± 2%
were investigated using quantitative MRI. Hematological and biochemical parameters were also assessed. All
subjects were free from major physical or intellectual impairment. Brain volumetric results were compared
with randomly selected age- and sex-matched controls from our database of normal subjects.
Results: Five of 10 cyanotic subjects had cortical lacunar infarcts. The white matter (WM) hyperintensity burden
was also abnormally high (Scheltens Scale was 8 ± 2). Quantitative MRI revealed evidence of extensive gener-
alized WM and gray matter (GM) volumetric loss; global GM volume was reduced in cyanosed subjects
(630 ± 16 vs. 696 ± 14 mL in controls, p = 0.01) as was global WM volume (471 ± 10 vs. 564 ± 18 mL,
p = 0.003). Ventricular cerebrospinal ﬂuid volume was increased (35 ± 10 vs. 26 ± 5 mL, p = 0.002). There
were widespread regions of local cortical thickness reduction observed across the brain. These changes included
bilateral thickness reductions in the frontal lobe including the dorsolateral prefrontal cortex and precentral gyrus,
the posterior parietal lobe and the middle temporal gyrus. Sub-cortical volume changes were observed in the
caudate, putamen and in the thalamus (p ≤ 0.005 for all regions). Cortical GM volume negatively correlated
with brain natriuretic peptide (R = −0.89, p = 0.009), high sensitivity C-reactive protein (R = −0.964,
p b 0.0001) and asymmetric dimethylarginine (R = −0.75, p = 0.026) but not with oxygen saturations,
packed cell volume or viscosity.
Conclusions:Wepresent the ﬁrst comprehensive analysis of brain structure in adults with chronic neurocyanosis
due to congenital heart disease. We demonstrate clear evidence for marked macro- and microvascular injury.
Cyanotic patients show global evidence for reduced brain volume as well as speciﬁc foci of cortical thickness
reduction. The GM volume loss correlated with hsCRP, BNP and ADMA suggesting that inﬂammation, neurohor-
monal activation and endothelial dysfunction may have important roles in its pathogenesis.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).CSF, cerebrospinal ﬂuid; CHD, congenital heart disease; GM, gray matter; hsCRP, high-sensitivity C-reactive protein; MRI, mag-
P, NT pro-brain natriuretic peptide; VBM, voxel-based morphometry; WM, white matter.
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Adults with cyanotic congenital heart disease (CHD) are the most
physically impaired of the adult CHD cohort and have a markedly im-
paired quality of life and a reduced life expectancy (Engelfriet et al.,
2005). The impact of chronic cyanosis on brain structure in these patients
has not been adequately characterized. Although the cyanotic CHD group
is phenotypically heterogeneous from a cardiac perspective, they share nu-
merous features that are unavoidable consequences of chronic cyanosis
such as hypoxemia, compensatory erythrocytosis, increasedblood viscosity
and endothelial dysfunction (Cordina and Celermajer, 2010). In childhood,
reduced gray matter (GM volume), white matter (WM) injury and im-
paired cognitive outcomeshavebeenwell-documented in the settingof cy-
anotic CHD (Owen et al., 2011) however such neurological consequences
are virtually uninvestigated in the adult population. Our study explores
the long-term consequences of cyanotic CHD on brain structure in adults.
Cerebral changes characterized by reduced brain volume and altered
metabolism have been demonstrated using magnetic resonance imag-
ing (MRI) and spectroscopy as early as the third trimester in fetuses
with cyanotic CHD. The exact mechanisms leading to these ﬁndings
are not precisely characterized but are likely, in part, a consequence of
reduced cerebral blood ﬂow (Limperopoulos et al., 2010; Clouchoux
et al., 2012). Reduced oxygen saturations have been found to strongly
correlate with reduced frontal GM volume in infants (Watanabe et al.,
2009). Brain growth is especially rapid in the ﬁrst 2 years of life; GM
reaches its maximum volume around 2 years of age whereas WM has
a slower growth process that continues through childhood (Zhang
et al., 2005). Thus, cyanosis may have differing neurological effects
depending on the developmental stage at which it occurs.
Clinical evidence of brain injury and altered brain structure in
children with cyanotic CHD is well described and has been reviewed
elsewhere(Owen et al., 2011). In contrast, data are lacking studying
the effects of chronic cyanosis in adults with CHD. The only substantive
data consists of a qualitative radiological study by Horigome et al. They
reported, seven of 15 subjects showed evidence of prior ischemic
events. Three subjects also had qualitatively “mild diffuse cortical atro-
phy”, however no quantitative brain volumes were measured.
Supporting a causative role for the degree of chronic cyanosis, the 8 sub-
jects in that study with a radiologically “normal”MRI had oxygen satu-
rations N85% in contrast to the subjects who had abnormal scans and
more severely reduced oxygen saturations (Horigome et al., 2006).
In this studywe examine a cohort of adults with cyanotic CHD and no
clinical history of stroke or known neurological deﬁcit. Our hypotheses
were: (1) that the radiological changes present in the adult population
would be dominated by the vascular consequences of cyanosis with
increased small vessel disease (WM hyperintensities) and large vessel
ischemic disease (lacunar infarcts) and (2) that the quantitativeMRI anal-
yses would show decreased overall GM and WM volumes in excess of
those expected due to normal aging. Finally, we sought to characterize
any potential relationships that might exist between brain volume and
several clinical and important laboratory parameters that reﬂect differing
aspects of the pathophysiology of chronic cyanosis such as inﬂammation,
endothelial dysfunction andneurohormonal activation.We chose 3 circu-
lating markers for measurement; ADMA is a potent nitric oxide synthase
inhibitor and marker of endothelial dysfunction (Vallance et al., 1992),
BNP reﬂects neurohormonal activation in heart failure (Iwanaga et al.,
2006) and hsCRP is an important acute phase reactant and inﬂammatory
marker (Anand et al., 2005). Our study represents the ﬁrst systematic
effort to understand the brain imaging changes occurring in this group.
2. Methods
2.1. Subjects
Ten consecutively consenting adultswith cyanotic CHD (3 females, 7
males) were recruited from the CHD database at Royal Prince Alfred
Hospital (RPAH), Sydney, Australia. The inclusion criterion was restingtranscutaneous oxygen saturations chronically≤90%. Exclusion criteria
were a contraindication toMRI, genetic abnormality or amajor physical
or intellectual impairment. Subject characteristics are shown in Table 1.
Age- and sex-matched controls for brain volumetric analysis were
drawn from the Brain Resource International Database, a standardized
database combining demographic, psychometric, physiological and
anatomical information. Exclusion criteria were any known neuro-
logical disorder, previous head injury, mental retardation, DSM-IV
Axis 1 diagnosis and history of drug dependence. MRI datasets
were acquired at Westmead Hospital (Sydney, Australia) (Grieve
et al., 2005; Paul et al., 2005).
Simpliﬁed cardiac anatomical characteristics for cyanotic CHD sub-
jects included atrioventricular septal defect with Eisenmenger physiol-
ogy (n = 3), ventricular septal defect with Eisenmenger physiology
(n = 1), ventricular septal defect with severe pulmonary stenosis
(n = 2, both with Blalock–Taussig shunt, 1 with Glenn shunt), pulmo-
nary atresiawith ventricular septal defect andmajor aorta to pulmonary
artery collaterals (n = 1), pulmonary atresia with intact septum
(n = 1, with Glenn shunt), pulmonary atresia with single ventricle
(n = 1, with Potts shunt) and pulmonary stenosis with essentially
single ventricle (n = 1, with Blalock–Taussig shunt).
Informed written consent was obtained from all subjects and the
study was approved by the Sydney Local Health District Ethics Review
Committee (RPAH Zone).
2.2. Study design
Study protocol included brain MRI with angiographic and volumet-
ric sequences. In addition, cyanotic CHD subjects also had hematological
and biochemical assessments that included a full blood count, NT pro-
brain natriuretic peptide (BNP), high-sensitivity C-reactive protein
(hsCRP) and asymmetric dimethylarginine (ADMA). Whole blood vis-
cosity was also measured (Brookﬁeld Digital Viscometer, rotational
speed of 12 rpm, shear rate 90 s−1). Functional capacity was assessed
with 6-minute walk test (6MWT).
2.3. Cerebral MRI
MRI imaging on the CHD cohort was performed using an 8-channel
head coil on the 1.5 Tesla Philips Achieva Scanner (Philips Medical Sys-
tems, Best, The Netherlands) at Specialist MRI, Sydney, Australia. The
imaging parameters were as follows: 3D SPGR — TR 8.3 ms, TE 4.6 ms,
Flip 30°, TI 500 ms, NEX 1, resolution 1 mm2, 1 mm sagittal slices;
DWI — TR 10 s, TE 140 ms, Fat Sat ON, NEX 1, resolution 1.72 mm2,
5 mm axial slices (skip 1.5 mm), 7 orientations, b = 1000; FSE — TR
4700 ms, TE 100 ms, NEX 1, resolution 0.6 mm2, 5 mm axial slices
(skip 1.5 mm); GRE — TR 747 ms, TE 23 ms, NEX 2, resolution
0.9 mm2, 5 mm coronal slices (skip 2 mm); MRA — TR 23 ms, TE
7 ms, NEX 1, resolution 0.6 mm2, 1.4 mm axial slices; and FLAIR — TI
2800 ms, TR 10 s, TE 140 ms, NEX 2, resolution 0.4 mm2, 5 mm slices
coronal (skip 2 mm).
Control data was acquired using a 1.5 Tesla Siemens (Erlangen,
Germany) Vision Plus system at Westmead Hospital as previously
described (Grieve et al., 2011a). MPRAGE sequence — TR 9.7 ms, TE
4 ms, ﬂip angle 12°, TI 200 ms, NEX 1, resolution 1 mm2, and 1 mm
sagittal slices.
Radiological reporting and scoring ofWMhyperintensity and lacunar
lesions were performed by a neuroradiologist (SMG). No clinical scoring
was performed for the control data due to a lack of FLAIR data for these
subjects. WM scoring was performed using the Scheltens Scale primarily
using the FLAIR data but with reference to the other T1W, T2W and DWI
datasets (Brickman et al., 2008; Scheltens et al., 1993). This is a semiquan-
titative method with good intra- and inter-observer reliability that sepa-
rates WM hyperintensities into periventricular (lateral bands, frontal
horn, occipital horn), lobar (frontal, temporal, parietal, and occipital),
infratentorial (cerebellum, medulla, pons, midbrain) and subcortical
Table 1
Cyanotic congenital heart disease subject characteristics.
All
(n = 10)
Normal range
Age (years) 40 ± 4 –
Body mass index (kg/m2) 23 ± 1 18.5–25.0
Blood pressure (mm Hg) 119 ± 3/67 ± 3 90–140/60–90
Oxygen saturations (%) 82 ± 2 N95%
6-Minute walk distance (m) 407 ± 35 NA
Hb (g/L) 195 ± 11 120–150
MCV (fL) 88 ± 4 80–99
PCV (L/L) 0.63 ± 0.03 0.36–0.46
Viscosity (centipoise) 10.4 ± 1.0 5.0–7.2
ADMA (μmol/L) 0.71 ± 0.06 NA
BNP (pmol/L) 153 ± 60 b13
hsCRP (mg/L) 3.36 ± 1.23 N3 associated with high CV risk
(Pearson et al., 2003)
Values are expressed as mean ± SEM (range).
ADMA = asymmetric dimethylarginine. BNP = NT pro-brain natriuretic peptide,
CV = cardiovascular, Hb = hemoglobin, hsCRP = high-sensitivity C-reactive
rotein, PCV = packed cell volume.
321R. Cordina et al. / NeuroImage: Clinical 4 (2014) 319–325regions (caudate, putamen, globus pallidus, internal capsule, and
thalamus). For ease of comparison with the WM hyperintensity scores,
lacunar infarcts (a measure of small arterial occlusion) were scored
using the same lobar, subcortical and infratentorial subdivisions using
a semiquantitative scale by assigning a score from 0 to 3 (0 = absent,
1 = mild (single lacune), 2 = moderate (2 lacunes), and 3 = severe
(3 lacunes or larger infarct)) for each region. Lacunar infarcts were
differentiated from Virchow–Robin spaces using the normal imaging
criteria (shape, size, location).
2.3.1. Brain volumetric analysis
Cortical reconstruction and volumetric segmentation was per-
formed with the Freesurfer image analysis suite, which is documented
and freely available for download online (http://surfer.nmr.mgh.
harvard.edu/). Freesurfer morphometric procedures have been demon-
strated to show good test–retest reliability across scanner manufac-
turers and across ﬁeld strengths and were preferred in our analysis for
this reason (Han et al., 2006). The technical details of these procedures
have been previously described elsewhere (Grieve et al., 2011b). Brieﬂy,
for each participant, the boundary between the GM and WM and the
outer surface of the cortex (the pial surface) was segmented. Cortical
thickness measurements at each point across the cortical mantle were
calculated as the closest distance from the GM/WM boundary to the
GM/cerebrospinal ﬂuid boundary. Each participant dataset was
then normalized to an average reference surface template in standard
space – provided with Freesurfer – to allow for cortical thickness
evaluations at every surface point across participants. Registration was
performed in a spherical surface-based coordinate system that is
adapted to the folding pattern of each individual dataset, allowing a
much higher localization accuracy of structural features of the brain
across participants (Fischl et al., 1999).
2.4. Plasma assays of vascular biomarkers
In order to understand potentially contributing factors to reduced
brain volume, 3 circulating markers were measured using enzyme-
linked immunosorbent assays (ADMA, BNP and hsCRP). Blood was col-
lected in K3EDTA-anticoagulated vacutainer tubes, (BD Biosciences,
Oxford, United Kingdom) and centrifuged for 15 minutes at 1000 x g
at 4 °C within 30 min of collection. Plasma was aliquoted and stored
at –80 °C until assayed. Plasma levels for ADMA, BNP and hsCRP were
quantiﬁed utilising commercially available ELISA kits according to the
manufacturer’s instructions (DLD Diagnostika GMBH, Hamburg,
Germany, R & D Systems, Minneapolis, United States, Bluegene Biotech,
Shanghai, China, BioVendor, Karasek, Czech Republic, respectively). All
measurements were read at 450 nM with reference wavelength asspeciﬁed by individual kits using a microplate spectrophotometer
(Benchmark Plus with Microplate Manager MPM 111 1.8 - version
10.2 Software, BioRad Laboratories, Hercules, United States).
2.5. 6-minute walk test
Two 6MWTswere performed on the same day. Subjects rested for at
least 10 min before performing the ﬁrst 6MWT and for a minimum of
30 min between tests and until oxygen saturation, dyspnea, and heart
rate returned to resting levels for the second test. All tests were per-
formed in the physiotherapy gymnasium at Royal Prince Alfred Hospital
on a continuous 32-m track marked with black tape for easy visibility.
Standardized instructions were given before each test, with encourage-
ment given each minute throughout the test (Anon, 2002).
Before and immediately after the walk test, oxygen saturations and
heart rate were monitored using a portable saturation monitor (RAD-5v
Masimo Corp, Irvine, United States).
2.6. Statistical analysis
Our primary hypothesis was that cyanotic CHD patients would show
abnormal quantitativeGMandWMmeasures, togetherwith an abnormal
burden of small vessel (WM hyperintensity) and large vessel ischemic
changes. These comparisons were performed using unpaired Student's t
tests between groups (datawere normally distributed). Secondary analy-
ses were performed using correlational analysis to evaluate the relation-
ship between brain volume (cortical GM and global WM volumes) and
oxygen saturations as well as important laboratory measurements. Due
to small sample sizes a Spearman's rank correlationwas used. Parameters
were not adjusted for Type I error as they were exploratory in nature, to
understand mechanisms. SPSS statistics Data Editor (IBM Corporation,
New York, USA) was used for statistical calculations. A two-tailed p-
value ≤ 0.05 was considered statistically signiﬁcant. All quantitative var-
iables are expressed as mean ± SEM and n (%) for qualitative data.
3. Results
3.1. Study group characteristics
Cyanotic CHD subject characteristics together with 6-minute walk
distance and relevant hematological and biochemical results are sum-
marized in Table 1. Two subjects had insufﬁcient serum for plasma anal-
ysis due to profound erythrocytosis. All subjects were NYHA Class II/III
(n = 5 were Class II and n = 5 were Class III). Medications were as
follows: bosentan n = 3, sildenaﬁl n = 1, statins n = 0, angiotensin
converting enzyme inhibitors n = 0, beta blockers n = 2, amiodarone
n = 1, aspirin n = 2, aspirin + persantin n = 1, warfarin n = 4, and
diuretics n = 3. The MRI control group (n = 19) was similar in age
(40.0 ± 9, p = 0.933) and gender (53% female, χ2 = 0.435).
3.2. Cerebral MRI
The summary results of clinical brain MRI reports along with WM
and lacunar infarct scores are presented in Table 2.
3.2.1. Brain volumes assessed at MRI
One subject's MRI data were unsuitable for volumetric analysis due
to motion artifact. Total intracranial volume was not different between
groups (cyanosed subjects: 1605 ± 42 mL vs. controls: 1598 ± 37 mL,
p = 0.914). Global GM volume was reduced in cyanosed subjects
(630 ± 16 mL vs. 696 ± 14 mL, p = 0.011). The majority of this dif-
ference (57%) was accounted for by supratentorial cortical GM loss
(337 ± 16 mL vs. 375 ± 9 mL, p = 0.031). The remaining volume
loss was mostly accounted for by subcortical structures (32% of total
GM loss; 182 ± 2 mL vs. 202 ± 6 mL, p = 0.033). No signiﬁcant dif-
ference in cerebellar GM volume was observed. When normalized by
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322 R. Cordina et al. / NeuroImage: Clinical 4 (2014) 319–325overall volume however, the percentage reduction in GM volume for
each of the cortical, subcortical and cerebellar categories was similar
at approximately 5%. Global WM volume was markedly reduced in
cyanosed subjects (471 ± 10 vs. 564 ± 18 mL, p = 0.003). Ventricular
cerebrospinal ﬂuid (CSF) volume (including lateral and 3rd ventricles
only) was greater in cyanosed subjects compared to controls
(35 ± 10 vs 26 ± 5 mL, p = 0.002); one subject, with aqueductal ste-
nosis, was excluded from CSF comparison.
The individual subcortical structures were evaluated using overall
volume measures. The volumes of the thalamus (p b 0.001), putamen
(p b 0.001), caudate (p = 0.005) were signiﬁcantly reduced in the
cyanotic group, the size of this reduction was similar for each region
at approximately 11%. The globus pallidus (p = 0.342) and the hippo-
campus–amygdala complex (p = 0.393) volumes did not differ
between groups.
3.2.1.1. Whole brain analysis of cerebral cortical thickness. The regional
pattern of cerebral cortical thickness loss was evaluated using a GLM
model including age, gender and global cerebral GM volume as co-
variates, these results are summarized in Table 3 and displayed in
Fig. 1. GM volume was included as a co-variate to control for the large
global GM changes present, therefore highlighting regions of increased
regional cortical thinning. Regions of locally reduced cortical thickness
were seen in the dorsal and lateral aspects of superior and middle fron-
tal gyrus — with focal changes present in the region corresponding to
the dorsolateral prefrontal cortex. Small bilateral clusters were also
present in the precentral gyrus and medially in the paracentral lobule.
In the parietal lobe bilateral changes were seen posteriorly in the supe-
rior, inferior and supramarginal gyri, andmedially in the precuneus. The
temporal lobe differences were limited to bilateral foci in the middle
temporal gyrus. Focally reduced left sided cortical thickness was also
present in the isthmus of the cingulate.
3.3. Analysis of relationship betweenMRI data, oxygen saturations and lab-
oratory measures
Cortical GM volume negatively correlated with BNP (R = −0.89,
p = 0.009), hsCRP (R = −0.964, p b 0.0001) and ADMA (R = −0.75,
p = 0.026). Cerebral WM volume correlated with 6-minute walk
distance (R = 0.643, p = 0.03). No signiﬁcant correlationwas detected
between assessed measures of brain volume and oxygen saturations,
packed cell volume or viscosity.
4. Discussion
In this report we present a comprehensive analysis of cerebral mor-
phology assessed with MRI in adults with cyanotic CHD. Cyanosed sub-
jects had reduced GM and WM volume compared with controls.
Cyanotic subjects also demonstrated advanced small vessel disease
(WM hyperintensities) and an abnormal burden of lacunar strokes. In
additional to the global trend, signiﬁcant regional reductions in cortical
thicknesswere detected— someofwhich involve foci relevant to higher
cognitive functions in the frontal lobe including the dorsolateral
prefrontal cortex and the precentral gyrus. In addition to this pattern
of regional cortical thinning, a selective pattern of bilateral subcortical
volume loss in the thalamus, putamen and the caudate was observed.
These ﬁndings may have important cognitive and psychological impli-
cations that require further characterization. Of the clinical and labora-
tory measures we examined — hsCRP, an inﬂammatory mediator, BNP,
amarker of neurohormonal activation and ADMA, amarker of endothe-
lial dysfunction, were found to be signiﬁcantly associated with more
severely reduced GM volume.
In our groupof cyanosed CHDadultswithoutmajor physical or intel-
lectual disability, we did not ﬁnd any signiﬁcant cerebral congenital
malformations apart from one subject who had aqueductal stenosis.
Three of 10 subjects had evidence of previous cerebral abscess, a well-
323R. Cordina et al. / NeuroImage: Clinical 4 (2014) 319–325documented complication of cyanotic CHD (Warnes et al., 2008). All
subjects had evidence for WM hyperintensities that were greater than
expected for the patient's age. Reference values for the frequency of
WM hyperintensities in the normal population do not yet exist, howev-
er the frequency in a population under 55 years would be expected to
be very low. A large study taken from the Helsinki Aging Brain study
reported periventricular WM hyperintensities in 21% of patients with
mean age of 62 years (range: 55–74 years) — compared to 90% of our
subjects with mean age of 40 years (Ylikoski et al., 1995). Additionally,
90% of our cyanotic patients had lacunar infarcts. In contrast, a recent
Australian study of 477 patients with mean age of 63 years (range:
60–64 years) reported the prevalence of lacunar infarcts to be 7.8%
(Chen et al., 2009).
The global GM volumes were reduced in cyanosed subjects. In addi-
tion, bilateral cortical thickness reductions were detected in the frontal,
parietal and temporal lobes. Notably, there were symmetric reductions
in dorsolateral prefrontal cortex thickness, an area known to be impor-
tant for higher-order roles including executive function. These regional
ﬁndings are similar to the regional vulnerability that is well described in
infants with cyanotic CHD, where reduced brain metrics in the frontal
and parietal lobes, cerebellum and brainstem have been demonstrated
(Ortinau et al., 2012). There has been no previous demonstration of
this type of heterogeneous volume loss in cyanotic adults. Interestingly,
Yan et al. reported that young adults who had grown up in high altitude
(a hypobaric hypoxic environment) also exhibited reduced precentral
gyri volumes (Yan et al., 2010). Although age-related GM change is ex-
tremely heterogeneous, the most marked volume loss tends to occur in
the dorsolateral prefrontal cortex and medial aspects of the superior
frontal gyrus, two of the regions shown in our study to be affected by
chronic cyanosis (Grieve et al., 2005, 2011b).
In addition to the GM volumetric change seen in our cohort we
observed decreased WM volume compared to controls. This ﬁnding is
in keeping with the known developmental changes associated with
cyanosis. WM injury has been well documented from soon after birth
(Ortinau et al., 2012; Miller et al., 2007; Block et al., 2010;
Andropoulos et al., 2010; Mahle et al., 2002; Beca et al., 2009; Shedeed
and Elfaytouri, 2011) — occurring in around one third of full-term in-
fants born with cyanotic CHD. Periventricular leukomalacia is thought
to result from reduced oxygen delivery to the vulnerable and immature
oligodendroglia in the process of myelination (Kinney et al., 2005; BackTable 3
Signiﬁcant regions of reduced cerebral cortical thickness in cyanotic congenital heart
disease subjects compared to controls (p b 0.01, FDR corrected).
Region Left/right MNI co-ordinates
x y z
Pre-central gyrus Right −4 −3 64
Left −14 2 52
Rostral middle frontal gyrus Right −8 85 24
Left −10 93 −22
Superior frontal (lat) Right −9 84 26
Left 9 62 43
Medial orbitofrontal Right −26 101 −24
Superior frontal (med) Right −31 78 15
Left 31 92 −6
Dorsolateral prefrontal cortex Right 19 58 14
Left −24 56 4
Isthmus of the cingulate gyrus Left 34 −33 14
Supramarginal gyrus Right 36 −10 29
Left −36 −40 23
Superior parietal lobule Right 0 −71 33
Left 2 −42 60
Inferior parietal lobule Right 31 −48 −6
Left −6 −86 11
Precuneus Right −30 −41 50
Left 28 −69 33
Middle temporal gyrus Right 36 −46 15
Left −41 −11 −45et al., 2006). The additional insult of ischemia related to low blood pres-
sure duringpalliative surgical procedures very early in lifemay also con-
tribute to cerebral injury (Mahle et al., 2002). Focal areas of cerebral
infarction have been documented in up to 10% of such infants pre-
operatively (Mahle et al., 2002; Beca et al., 2009; Licht et al., 2009).
Our cohort was too small for meaningful subgroup analysis to examine
whether subjects with early life cyanosis (non-Eisenmenger) during
critical stages of brain development and growth had more profound
WM alteration or greater reduction in brain volume compared to
those subjects who developed cyanosis later in life (Eisenmenger).
Our association analysis suggests that not all of the alterations in
brain volume we observed are necessarily developmental. Lower oxy-
gen saturations did not appear to be associated with cerebral volume
suggesting that it may not simply be hypoxemia underlying the reduc-
tion in brain volume thatwe observed. Compensatory erythrocytosis re-
sults from chronic cyanosis increasing blood viscosity and shear stress
on vessel walls (Cordina and Celermajer, 2010). This might result
in varying degrees of endothelial inﬂammation and dysfunction
(Oechslin et al., 2005) with resultant damage to cerebral tissue down-
stream. This hypothesis is further supported by our other ﬁndings:
while no strong relationship existed between the expected markers of
cyanosis (packed cell volume and oxygen saturations) and GM volume,
markers of endothelial dysfunction (ADMA), heart failure (BNP) and
inﬂammation (hsCRP) showed a negative correlation. Data from the
Framingham Study have shown that inﬂammatory markers are nega-
tively associated with brain volume (Jefferson et al., 2007) and that
ADMA is associated with increased risk of silent brain infarction even
after adjustment for traditional risk factors (Pikula et al., 2009) suggest-
ing that individual inﬂammatory and endothelial responses might have
an important role in brain atrophy and ischemic change. It is possible
that similar, more pronounced mechanisms are import contributors to
neural injury in the setting of chronic cyanosis and that interrupting
these pathways with anti-inﬂammatory or targeted endothelial thera-
pies might provide neuroprotection. We found a positive association
existed between functional status (6-minute walk distance) and WM
volume. Whether this reﬂects a causative relationship is yet to be char-
acterized but it is possible that WM injury has important implications
for physical capacity.
4.1. Clinical relevance
Chronic cyanosis has been found to affect attention span, intellect
and motor development in children and adolescents with CHD (Bass
et al., 2004) but data do not exist for the adult population. The general
lack of data in this area may be partly explained by the heterogeneity
of the group; underlying cardiac anatomy and cardiopulmonary physi-
ology, the age that cyanosis develops (that may impact profoundly
upon neurological development) and in utero cerebral hemodynamics
are just 3 of many characteristics that differ vastly across the group. In
addition, there may exist a pervading view that, in general, subjects sel-
dom survive long into adulthood however large European series have
reported a median age of 29 years for the adult cyanotic CHD group
and recent literature focused on subjects with Eisenmenger syndrome
has reported a mean age between 35 and 40 years (Moceri et al.,
2012; Dimopoulos et al., 2010).We have found that important brain ab-
normalities exist in these adults. It is likely that these major alterations
in brain structure have important effects on neurological functioning
that warrant further characterization.
4.2. Limitations
This report was limited by small subject numbers and the group we
studied was heterogeneous. Subjects had differing underlying cardiac
anomalies and/or vascular arrangement and the small sample size
prevented further subgroup analysis, however, the marked abnormali-
ties we found suggest that signiﬁcant cerebral abnormalities are
Fig. 1. Signiﬁcant clusters of regionally reduced cortical thickness in neurocyanotic patients versus controls. The scale ranges from−5 to+5−log10(p), where p = 0.05 is 1.3, p = 0.001
is 3.
324 R. Cordina et al. / NeuroImage: Clinical 4 (2014) 319–325widespread in this group. Due to the myriad of factors that likely
contribute to altered neurological structure in these adults isolating a
primary pathogenic mechanism for the changes we observed was not
possible and although our correlation analysis provided some interest-
ing associations, these calculations must be interpreted cautiously in
the context of low numbers. Our matched controls were drawn from a
database which did not contain T2 or FLAIR imaging data, preventing
an accurate direct comparison for this current investigation for WM
hyperintensity score and lacunar infarct quantiﬁcation. The different
sites of MRI acquisition between the control and cyanotic subjects in
our study are a limitation. In order to partially ameliorate this factor
we used Freesurfer, a robust technique that is well-characterized for
the analysis of multi-site datasets in an attempt to minimize the poten-
tial inﬂuence of site. The structural abnormalities present in the group
(one subject with aqueductal stenosis and three patients with focal
regions corresponding to prior cerebral abscesses) do represent a po-
tential compromise of the volumetric and cortical analyses. The subject
with aqueductal stenosis was excluded from CSF comparison. Masking
of the foci of prior abscesses was felt unnecessary as the local cortical
architecture was preserved, and visual inspection of the processed
data did not suggest any abnormal results in the overlying cortical
values.
5. Conclusions
Adults with cyanotic CHD have evidence formarkedmacro- andmi-
crovascular injury aswell as reduced GM andWMvolume andmultiple
foci of reduced regional cortical thickness. The clinical signiﬁcance and
pathophysiology underlying these ﬁndings is yet to be fully character-
ized. Inﬂammation, neurohormonal and endothelial dysfunction may
have important roles in pathogenesis.
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